New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…
Bravo Flowdex: How This Innovative Platform is Redefining AI Trading Read Bravo Flowdex Spain Report!
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction –…
Multiple Myeloma Research Foundation (MMRF) Announces New Data from Flagship Research Initiatives at the 22nd International Myeloma Society Annual Meeting
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma…
Revive Therapeutics Announces Closing of Second Tranche of Private Placement
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or…
Huawei Unveils Xinghe AI Campus Full-Scope Security Solution, Pioneering a New Paradigm for Campus Protection in the AI Era
SHANGHAI, Sept. 19, 2025 /PRNewswire/ -- During HUAWEI CONNECT 2025, Huawei unveiled…
Huawei Charts the Future of Smart Technology with Pioneering Product Lineup
PARIS, Sept. 19, 2025 /PRNewswire/ -- Today, under the banner of "Ride…
CisionOne Expands AI-Powered Platform with Enhanced Instant Insights and Social Intelligence
Innovative upgrades unify traditional, social and media release distribution—giving PR teams faster,…
Hyundai Motor Group to Showcase AI, Robotics and Mobility Innovation at 2025 ZER01NE DAY
Hyundai Motor Group to host the 2025 ZER01NE Day from September 17…
Rising Star ASTRAUX Shines at IFA Berlin, Accelerates Expansion Across Key EU Markets
BERLIN, Sept. 8, 2025 /PRNewswire/ -- Dubai-based lifestyle tech brand ASTRAUX made…
CGI wins Gold in Brandon Hall Group HCM Excellence Award 2025
Recognized for 'Best Unique or Innovative Learning and Development Program' BANGALORE, India,…